EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interferon alpha-inducible protein 27 (IFI27) inhibits hepatitis B virus (HBV) transcription through downregulating cellular transcription factor C/EBPα

Xiaoyang Yu, Cheng-Der Liu, Sheng Shen, Elena S Kim, Zhentao Liu, Hu Zhang, Ning Sun, Yuanjie Liu, Pia M Martensen, Yufei Huang, Haitao Guo iD

Journal of Virology · 25.11.2025 · 99 (11)

DOI: 10.1128/jvi.01509-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 25.11.2025. Verfasst von Xiaoyang Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Hepatitis B virus, Membrane Proteins, Transcription, Genetic, CCAAT-Enhancer-Binding Protein-alpha. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferon alpha (IFNα) is the only approved immunomodulatory drug for chronic hepatitis B treatment, exerting its antiviral effects through the induction of interferon-stimulated genes (ISGs). To identify key antiviral ISGs that inhibit hepatitis B virus (HBV) replication, we performed transcriptome analysis of IFNα-treated HepG2-NTCP cells and found that IFI27 was among the most differentially expressed genes. The high inducibility of IFI27 by IFNα was further validated in primary human hepatocytes. Overexpression of IFI27 significantly suppressed HBV replication in both HBV-transfected and -infected cells, primarily by reducing HBV RNA transcription. Conversely, IFI27 knockdown markedly diminished the antiviral effect of IFNα in HBV-infected cells. IFI27 is predominantly localized in the cytoplasm, and RNA-seq analysis revealed that IFI27 inhibits HBV transcription without drastically altering the host transcriptome, indicating that IFI27 does not inhibit HBV transcription directly or through altering the transcription of cellular transcription factors or inducing antiviral signaling pathways. Instead, we found that IFI27 suppresses HBV transcription by promoting the ubiquitination-dependent proteasomal degradation of C/EBPα in the cytoplasm, a cellular transcription factor critical for HBV RNA transcription. Further investigation identified the E3 ubiquitin ligase SKP2 as a key mediator of this process, facilitating IFI27-induced C/EBPα ubiquitination and degradation. Notably, SKP2 knockdown abrogated IFI27’s antiviral activity against HBV. Taken together, our findings reveal that IFI27 contributes to IFNα-mediated antiviral activity against HBV by targeting C/EBPα for SKP2-dependent ubiquitination and proteasomal degradation. This study thus sheds new light on the antiviral mechanism of IFNα-based therapy for chronic hepatitis B. IMPORTANCE Chronic hepatitis B virus (HBV) infection affects approximately 250 million people worldwide with limited treatment options. Interferon alpha (IFNα) remains the only approved immunomodulatory treatment for chronic hepatitis B, working in HBV-infected liver cells through inducing antiviral genes. To identify key interferon-inducible genes involved in HBV suppression, we performed transcriptome analysis of IFNα-treated liver cells and identified IFI27 as one of the most upregulated genes. Functional studies demonstrated that IFI27 inhibits HBV replication by reducing viral RNA transcription, and its knockdown significantly impaired the antiviral effect of IFNα. Mechanistically, IFI27 suppresses HBV transcription by promoting the ubiquitin-proteasome-mediated degradation of C/EBPα, a transcription factor critical for HBV RNA synthesis. This process is dependent on the E3 ubiquitin ligase SKP2, as SKP2 knockdown abolished IFI27-mediated antiviral activity. These findings reveal IFI27 as a critical mediator of IFNα-induced antiviral responses against HBV and provide new insights into host-directed antiviral mechanisms with potential therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusMembrane ProteinsTranscription, GeneticCCAAT-Enhancer-Binding Protein-alphaHumansInterferon-alphaVirus ReplicationHep G2 CellsHepatocytesAntiviral AgentsDown-RegulationUbiquitinationHost-Pathogen InteractionsCCAAT-Enhancer-Binding Proteins

Stichwörter der Autor:innen

HBVIFI27

Substanzen

Interferon-alphaIFI27 protein, humanMembrane ProteinsAntiviral AgentsCEBPA protein, humanCCAAT-Enhancer-Binding Protein-alphaCCAAT-Enhancer-Binding Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Cancer Virology Program, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
  • Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Electrical and Computer Engineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Haitao Guo

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Yu, X., Liu, C. D., Shen, S., Kim, E. S., Liu, Z., Zhang, H., Sun, N., Liu, Y., Martensen, P. M., Huang, Y., & Guo, H. (2025). Interferon alpha-inducible protein 27 (IFI27) inhibits hepatitis B virus (HBV) transcription through downregulating cellular transcription factor C/EBPα. Journal of Virology, 99(11). https://doi.org/10.1128/jvi.01509-25

Vancouver

Yu X, Liu CD, Shen S, Kim ES, Liu Z, Zhang H, et al. Interferon alpha-inducible protein 27 (IFI27) inhibits hepatitis B virus (HBV) transcription through downregulating cellular transcription factor C/EBPα. Journal of Virology. 2025;99(11). doi:10.1128/jvi.01509-25

BibTeX
@article{Yu2025,
  author = {Yu, Xiaoyang and Liu, Cheng-Der and Shen, Sheng and Kim, Elena S and Liu, Zhentao and Zhang, Hu and Sun, Ning and Liu, Yuanjie and Martensen, Pia M and Huang, Yufei and Guo, Haitao},
  title = {Interferon alpha-inducible protein 27 (IFI27) inhibits hepatitis B virus (HBV) transcription through downregulating cellular transcription factor C/EBPα},
  journal = {Journal of Virology},
  year = {2025},
  volume = {99},
  number = {11},
  doi = {10.1128/jvi.01509-25}
}
Kostenlos starten →